InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard neuroprotection system for transcarotid access and neuro protection, as well as treating acute stroke with tandem lesions. It has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Miami, Florida. Show more
Location: 6303 Waterford District Drive, Miami, FL, 33126, United States | Website: https://www.inspiremd.com | Industry: Medical Devices | Sector: Healthcare
Market Cap
101.4M
52 Wk Range
$1.99 - $3.80
Previous Close
$2.43
Open
$2.45
Volume
37,888
Day Range
$2.40 - $2.45
Enterprise Value
84.6M
Cash
19.37M
Avg Qtr Burn
-7.394M
Insider Ownership
18.19%
Institutional Own.
32.86%
Qtr Updated
06/30/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|